e-learning
resources
European Respiratory Review
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals
Sitbon O., Galiè N.
Source:
Eur Respir Rev 2010 19: 272-278
Journal Issue:
December 2010 - 19 (118)
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sitbon O., Galiè N.. Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals. Eur Respir Rev 2010 19: 272-278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Management of severe pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 279-287
Year: 2010
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 589-596
Year: 2012
Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management
Source: Eur Respir Rev 2010 19: 314-320
Year: 2010
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018
Year: 2019
A regional nurse study day using small group tutorials- A successful novel approach to publicising pulmonary hypertension
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Effect of sildenafil on exercise ability of patients with World Health Organization functional class II pulmonary arterial hypertension
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Pulmonary hypertension: diagnosis, differential diagnosis and pitfalls
Source: Eur Respir Mon 2012; 57: 17-25
Year: 2012
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Issues related to the management and therapy of paediatric pulmonary hypertension
Source: Eur Respir Rev 2010 19: 331-339
Year: 2010
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Source: Eur Respir J 2010; 35: 1079-1087
Year: 2010
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs
Source: Eur Respir Rev 2009; 18: 18-23
Year: 2009
Pulmonary hypertension: new guidelines for therapy
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007
An evaluation of outcomes for patients with pulmonary hypertension (PH) incorporated into a standard UK pulmonary rehabilitation (PR) programme
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Treatment options for paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 321-330
Year: 2010
The role of right heart catheterization prior to initiation of PAH specific therapy
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept